UPDATED May 06, 2024
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ARES | US$136.17 | 0.9% | 66.1% | US$41.7b | US$146.50 | PE61.3x | E41.9% | 2.7% | Diversified Financials | ||
NVDA | US$921.40 | 5.0% | 216.1% | US$2.3t | US$1,002.20 | PE76.2x | E23.4% | 0.02% | Semiconductors | ||
A247540 | ₩226,000.00 | -5.2% | -4.6% | ₩22.1t | ₩238,880.00 | PS3.2x | E38.6% | 0% | Capital Goods | ||
NU | US$12.00 | 9.0% | 102.7% | US$57.2b | US$12.54 | PB8.9x | E32.1% | n/a | Banks | ||
300308 | CN¥176.79 | -5.1% | 115.8% | CN¥144.1b | CN¥193.28 | PE47.4x | E28.3% | 0.3% | Tech | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
BESI | €127.15 | -0.08% | 48.3% | €9.8b | €147.51 | PE55.5x | E26.5% | 1.7% | Semiconductors | ||
PDD | US$138.64 | 10.8% | 125.8% | US$192.2b | US$181.10 | PE23.1x | E22.9% | n/a | Retail | ||
WTC | AU$96.43 | 3.9% | 41.8% | AU$31.2b | AU$88.99 | PE144.1x | E27.2% | 0.2% | Software | ||
2382 | NT$266.50 | 2.5% | 190.3% | NT$1.0t | NT$308.82 | PE25.9x | E22.3% | 3.4% | Tech | ||
LI | US$29.20 | 8.3% | 18.0% | US$31.0b | US$46.99 | PE19.1x | E22.0% | n/a | Automobiles | ||
601127 | CN¥86.98 | -4.6% | 214.0% | CN¥137.7b | CN¥108.13 | PS2.3x | E42.9% | 0% | Automobiles | ||
SMCI | US$830.35 | -6.7% | 507.7% | US$48.6b | US$1,006.68 | PE46.3x | E37.6% | n/a | Tech | ||
CG | US$41.99 | -9.3% | 60.8% | US$15.1b | US$49.33 | PS6.8x | E23.6% | 3.3% | Diversified Financials | ||
2371 | CN¥317.10 | -0.6% | 5.3% | CN¥169.3b | CN¥386.52 | PE38x | E25.1% | 0.2% | Semiconductors | ||
603392 | CN¥70.23 | 2.9% | 1.0% | CN¥87.8b | CN¥70.40 | PE693.3x | E63.0% | 0.5% | Pharmaceuticals & Biotech | ||
600989 | CN¥17.29 | 4.2% | 34.9% | CN¥124.9b | CN¥23.40 | PE21.5x | E34.0% | 1.6% | Materials | ||
OWL | US$18.39 | -3.4% | 78.7% | US$25.9b | US$21.25 | PE129.5x | E86.0% | 3.9% | Diversified Financials | ||
SYM | US$41.94 | 4.2% | 49.3% | US$24.1b | US$54.27 | PS3x | E115.8% | n/a | Capital Goods | ||
DUOL | US$248.20 | 8.4% | 88.3% | US$10.7b | US$251.60 | PE665.6x | E54.9% | n/a | Consumer Services | ||
6669 | NT$2,340.00 | -0.8% | 109.9% | NT$399.5b | NT$2,722.47 | PE34x | E32.0% | 2.1% | Tech | ||
CELH | US$78.33 | 6.2% | 119.8% | US$18.3b | US$92.09 | PE100.3x | E23.4% | n/a | Food, Beverage & Tobacco | ||
APOLLOHOSP | ₹6,056.70 | 1.5% | 31.0% | ₹870.9b | ₹6,846.88 | PE110.3x | E35.5% | 0.2% | Healthcare | ||
DLF | ₹887.10 | 0.1% | 103.3% | ₹2.2t | ₹859.83 | PE92.4x | E28.5% | 0.5% | Real Estate Management and Development |